We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Widecells Group Plc | LSE:WDC | London | Ordinary Share | GB00BD060S65 | ORD GBP0.0025 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.285 | 0.28 | 0.29 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/11/2018 00:22 | It's a relatively new company trying to expand too fast. | leader11 | |
01/11/2018 23:47 | Cellplan is expanding rapidly in areas of the world. | leader11 | |
01/11/2018 22:58 | Sorry it's dated 2/11/2017 not 2018. | leader11 | |
01/11/2018 22:57 | This I found very interesting to read about earning revenues.Dated rns 2/11/2018.partial read.Overview -- Binding agreement with White Apex to transform revenue and value potential of WideCells Group -- GBP255,000 payable to WideCells Group immediately - for initial set up of WideCells stem cell collection and dispatch services and sponsorship of Wideacademy subscriptions for 2,000 doctors per year for three years -- Multi-million pound recurring revenues expected from all three divisions: o CellPlan - sale of innovative stem cell insurance producto WideCells - sale of stem cell storage and INDUS synthetic bone productso Wideacademy - sale of subscriptions to the educational platform (2,000 doctors already subscribed) and educational / training accreditation-- Further GBP1,500,000 potentially payable for the adaptation of Wideacademy's innovative educational platform for use in MENA and Asia-Pacific regions:o GBP250,000 potentially to be paid by the end of the year, to be followed by two additional payments of GBP250,000 due for the next two years thereafter, for MENA adaptationo GBP250,000 potentially to be paid the end of Q1 2018, to be followed by two additional payments of up to GBP250,000 due for the next two years thereafter, for Asia-Pacific adaptation-- Established a regional office in Dubai to facilitate commercial roll-out - led by Dr. Ahmed Al-Alawi, a pre-eminent stem cell scientist with notable corporate experience and regional connectionsWideCells Group CEO, João Andrade, said, "We are delighted to have finalised this landmark agreement with White Apex and accordingly now be selling our innovative stem cell services and regenerative health products in the MENA and Asia-Pacific regions. This is a multi-million-pound deal: with GBP255,000 payable to us immediately and significant recurring revenues expected to commence thereafter from all three of our divisions, this sales agreement is set to transform our company. Stem cells are revolutionising the medical world, and as we build our global reach we are also able to promote and support the development of this rapidly growing area of medicine so that more and more people can benefit from and have access to this potentially life-saving treatment."White Apex make the perfect partner for us. Thanks to their unrivalled regional experience and connections within the MENA and Asia-Pacific territories, we are able to rapidly build our global presence and commercial reach. Furthermore, having strengthened the terms of the binding agreement compared to those agreed in the initial heads of terms, their belief in the value of our proposition is clear: the agreement has been extended from three to five years and also now includes Turkey. We look forward to working closely with them to build revenues across all three of our divisions within this highly prospective region." | leader11 | |
01/11/2018 22:49 | https://m.youtube.co | leader11 | |
01/11/2018 22:27 | 1bhs, certainly a lot more optimistic now that Peter Presland is getting a grip of the business, ....GL S | swizz | |
01/11/2018 16:04 | Interesting that Miton bought 10% at much higher levels in July and haven't disposed of any | 1bluehorseshoe | |
01/11/2018 14:50 | More awareness on wideacadamey, will teach clients.Did anyone check out the audio interview ..any thoughts. | leader11 | |
01/11/2018 14:25 | Yes Leader it all looks exceptional if only they knew how to run a business | 1bluehorseshoe | |
01/11/2018 14:22 | Smart cells got clients world wide. | leader11 | |
01/11/2018 11:58 | I take it you're positive about our prospects here then swizz? | 1bluehorseshoe | |
01/11/2018 11:33 | Agm on 15/11/18 | leader11 | |
01/11/2018 08:38 | Issue of equity definitely for W. I. P has to be good for company turn around. | leader11 | |
31/10/2018 22:34 | Listen 5.20mins into audio you'll like it A LOT. | leader11 | |
31/10/2018 22:29 | https://vimeo.com/23 | leader11 | |
31/10/2018 21:58 | https://m.youtube.co | leader11 | |
31/10/2018 21:10 | https://www.mumsnet. | leader11 | |
31/10/2018 19:28 | It is worth noting that the recent changes, alter in a material way the amount of funding needed, this in itself along with the Smarcells deal may move the BOD in a different direction,.....GL S | swizz | |
31/10/2018 16:27 | Still higher than its average. Two weeks to go before the General Meeting and plenty of room on the RSI. A breather after a sharp rise is quite normal and healthy | 1bluehorseshoe | |
31/10/2018 16:17 | Low volume today | leader11 | |
31/10/2018 12:52 | I know I'm close to having to write a TR1 lol | 1bluehorseshoe | |
31/10/2018 12:41 | It's a steal at these level of share price | leader11 | |
31/10/2018 12:38 | 1bluehorseshoe. I hope it all picks up at their Wideacademy. I'm just dyor.It will attract investors and spread the knowledge of stem cells banking. | leader11 | |
31/10/2018 12:17 | Great research Leader, thanks for posting everything | 1bluehorseshoe |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions